This gut microbe may help keep you strong as you age

If you've ever wondered why some people seem to hang onto their strength as they age while others don't, the answer may partly live in the gut. A new study in the journal Gut has identified a single bacterial species, Roseburia inulinivorans, whose presence tracked with meaningfully higher grip strength in older adults, and whose effects held up when researchers tested it directly in mice. For anyone managing sarcopenia (age-related muscle loss) or simply trying to stay strong into old age, this is one of the first times a specific gut microbe has been causally linked to muscle function rather than just correlated with it.

KEY TAKEAWAYS

• Older adults carrying Roseburia inulinivorans in their gut had 29% higher handgrip strength than those without it, and the bacterium was also linked to leg press and bench press strength in a separate cohort of young adults.
• When researchers gave the bacterium to mice, it directly increased forelimb grip strength by about 30% and made muscle fibers larger, evidence this is a cause and not just a coincidence.
• The bacterium works by changing amino acid availability and activating energy pathways in muscle rather than through the short-chain fatty acids (fermentation byproducts) Roseburia is best known for.
• This is early-stage science. The human findings are observational, R. inulinivorans is not an approved supplement, and no human trial of supplementation has been done yet.

Roseburia Inulinivorans Tracks With Human Grip Strength

Researchers found that people carrying detectable levels of the gut bacterium Roseburia inulinivorans (a species that lives in the large intestine and ferments dietary fiber) had noticeably stronger muscles than those without it. In a cohort of 33 older adults (average age 68), those with detectable R. inulinivorans in their stool had handgrip strength 29% higher than those without it, a difference that held even though the two groups had similar aerobic fitness. In a separate cohort of 90 young adults, people with higher relative abundance of the bacterium also had stronger handgrip, leg press and bench press strength, plus higher peak oxygen uptake (VO2 peak, a measure of cardiorespiratory fitness). Notably, two closely related Roseburia species, R. faecis and R. intestinalis, showed none of these associations, which points to something specific about R. inulinivorans rather than the wider Roseburia genus.

Why Age-Related Muscle Loss Makes This Finding Matter

Loss of muscle mass and strength, seen in conditions like sarcopenia and cachexia (severe muscle wasting often tied to chronic illness or cancer), is a major driver of frailty, falls and loss of independence in older adults. There is currently no gut-targeted treatment for it: management leans almost entirely on resistance exercise and adequate protein intake. The researchers also found that R. inulinivorans levels were lower in their older adult cohort than in the young adult cohort, and the bacterium has separately been reported to be depleted in people with sarcopenia, as well as in other muscle-wasting-associated conditions such as cerebral palsy and cancer cachexia. That pattern, a beneficial microbe that seems to fade with age right as muscle loss accelerates, is what makes this more than a curiosity for anyone already thinking about their gut health and their strength as they get older.

How Researchers Tested Cause and Effect, Not Just Correlation

Human microbiome studies are notoriously prone to reverse causation: maybe stronger people simply have different diets or lifestyles that happen to favor certain bacteria, rather than the bacteria causing the strength. To get past that, the team moved from humans into mice. They took 32 male mice, wiped out their existing gut bacteria with a two-week course of antibiotics, then split them into four groups that received either a control solution or one of three Roseburia species, delivered by mouth three times a week for eight weeks. Only the group receiving R. inulinivorans showed a meaningful change: forelimb grip strength rose by roughly 30% compared to control mice by four weeks, and stayed elevated through eight weeks. The other two Roseburia species did nothing to strength. The R. inulinivorans mice also developed larger muscle fibers with more of the fast-twitch (type II) fibers used for short bursts of power, like lifting or sprinting, rather than endurance. Tellingly, none of the bacteria improved the mice's running endurance, suggesting the effect is specific to strength rather than stamina.

What This Could Mean If You're Managing Your Own Muscle Health

It's tempting to read a 29% grip strength difference and 30% mouse improvement and think "I should find this bacterium in a supplement." That would be premature. R. inulinivorans is not currently sold as a validated probiotic, no human trial has tested giving it as a supplement, and the researchers themselves describe it only as a "candidate" for future nutraceutical development. What is worth knowing is the underlying signal: your gut microbiota composition may be one more variable, alongside resistance training and dietary protein, that connects to how well you maintain strength as you age. If you are already researching sarcopenia or muscle loss for yourself or a family member, this is a reasonable study to mention to a doctor or dietitian as an emerging area, not a green light to seek out this specific bacterium.

Why the Effect Doesn't Work Through Butyrate

Roseburia species are best known in the microbiome field as prolific producers of butyrate, a short-chain fatty acid (a compound gut bacteria make by fermenting fiber) that is widely credited with supporting gut lining health and reducing inflammation. This study found the muscle-strengthening effect of R. inulinivorans had nothing to do with butyrate or other short-chain fatty acids, which were unchanged across all treatment groups. Instead, the bacterium lowered concentrations of several amino acids, including methionine, leucine and lysine, in the gut and bloodstream, while activating the purine and pentose phosphate pathways (cellular processes that generate the building blocks for new DNA, RNA and energy) inside muscle tissue. The researchers propose that because R. inulinivorans cannot make its own amino acids as efficiently as related species, it competes for amino acids in the gut, and the host may respond by rerouting the amino acids it does have toward muscle repair and growth. It is a genuinely new mechanism for a gut-muscle connection, and one the study's authors say needs more direct investigation.

What Remains Unproven and What Comes Next

Several limits are worth keeping in mind. The human data is observational: it shows an association between the bacterium and strength, not proof that the bacterium caused the strength difference in people, since longitudinal studies would be needed to establish which came first. The mouse experiment establishes causality, but only in mice, and even there the bacterium never permanently colonized the gut; it was undetectable within days of the last dose, meaning the effect likely comes from a transient exposure or its metabolites rather than the bacterium taking up permanent residence. The antibiotic pretreatment used to clear the mice's native gut bacteria is also itself a departure from normal physiology. The authors are explicit that the next step is a proper human intervention trial testing oral supplementation with R. inulinivorans, which has not yet been conducted, to see whether deliberately raising its levels actually improves strength in people, not just mice.

Common Questions

Is Roseburia inulinivorans available as a probiotic supplement? No. It is not currently sold as a tested, regulated probiotic, and this study did not test giving it to people as a supplement, only observing its natural levels in stool and testing it directly in mice.

Does this mean fiber or diet changes could raise my levels of this bacterium? The study did not test any dietary intervention or find a link between R. inulinivorans levels and reported fiber, protein or carbohydrate intake, so it cannot yet answer that question directly.

Why did the effect happen through amino acids and not the short-chain fatty acids Roseburia is known for? The researchers measured short-chain fatty acids directly and found no differences between treatment groups, while amino acid and muscle energy pathway changes were substantial, which is why they point to that as the likely mechanism instead.

Could this bacterium eventually treat sarcopenia? That is the researchers' long-term hope, and they call it a "promising probiotic candidate," but that would require a human clinical trial testing supplementation directly, which has not yet been done.

References

Borja Martinez-Tellez, Milena Schönke, Artemiy Kovynev, et al. (2026). Roseburia inulinivorans increases muscle strength. Gut. https://doi.org/10.1136/gutjnl-2025-336980